rs9278

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004935.4(CDK5):​c.*116G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.187 in 857,168 control chromosomes in the GnomAD database, including 16,668 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 2080 hom., cov: 32)
Exomes 𝑓: 0.19 ( 14588 hom. )

Consequence

CDK5
NM_004935.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.912

Publications

8 publications found
Variant links:
Genes affected
CDK5 (HGNC:1774): (cyclin dependent kinase 5) This gene encodes a proline-directed serine/threonine kinase that is a member of the cyclin-dependent kinase family of proteins. Unlike other members of the family, the protein encoded by this gene does not directly control cell cycle regulation. Instead the protein, which is predominantly expressed at high levels in mammalian postmitotic central nervous system neurons, functions in diverse processes such as synaptic plasticity and neuronal migration through phosphorylation of proteins required for cytoskeletal organization, endocytosis and exocytosis, and apoptosis. In humans, an allelic variant of the gene that results in undetectable levels of the protein has been associated with lethal autosomal recessive lissencephaly-7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]
CDK5 Gene-Disease associations (from GenCC):
  • lissencephaly 7 with cerebellar hypoplasia
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.232 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK5NM_004935.4 linkc.*116G>A 3_prime_UTR_variant Exon 12 of 12 ENST00000485972.6 NP_004926.1 Q00535-1A0A090N7W4
CDK5NM_001164410.3 linkc.*116G>A 3_prime_UTR_variant Exon 11 of 11 NP_001157882.1 Q00535-2A0A0S2Z355

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK5ENST00000485972.6 linkc.*116G>A 3_prime_UTR_variant Exon 12 of 12 1 NM_004935.4 ENSP00000419782.1 Q00535-1
CDK5ENST00000297518.4 linkc.*116G>A downstream_gene_variant 1 ENSP00000297518.4 Q00535-2

Frequencies

GnomAD3 genomes
AF:
0.152
AC:
23106
AN:
152030
Hom.:
2081
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0768
Gnomad AMI
AF:
0.140
Gnomad AMR
AF:
0.125
Gnomad ASJ
AF:
0.167
Gnomad EAS
AF:
0.0135
Gnomad SAS
AF:
0.243
Gnomad FIN
AF:
0.137
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.209
Gnomad OTH
AF:
0.155
GnomAD4 exome
AF:
0.194
AC:
137027
AN:
705020
Hom.:
14588
Cov.:
9
AF XY:
0.197
AC XY:
70981
AN XY:
360922
show subpopulations
African (AFR)
AF:
0.0720
AC:
1226
AN:
17028
American (AMR)
AF:
0.107
AC:
2172
AN:
20276
Ashkenazi Jewish (ASJ)
AF:
0.164
AC:
2614
AN:
15930
East Asian (EAS)
AF:
0.0104
AC:
336
AN:
32240
South Asian (SAS)
AF:
0.243
AC:
13123
AN:
54078
European-Finnish (FIN)
AF:
0.146
AC:
5421
AN:
37240
Middle Eastern (MID)
AF:
0.203
AC:
507
AN:
2496
European-Non Finnish (NFE)
AF:
0.214
AC:
105382
AN:
491432
Other (OTH)
AF:
0.182
AC:
6246
AN:
34300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
5578
11157
16735
22314
27892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2414
4828
7242
9656
12070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.152
AC:
23113
AN:
152148
Hom.:
2080
Cov.:
32
AF XY:
0.146
AC XY:
10895
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0767
AC:
3185
AN:
41542
American (AMR)
AF:
0.125
AC:
1910
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.167
AC:
580
AN:
3470
East Asian (EAS)
AF:
0.0135
AC:
70
AN:
5170
South Asian (SAS)
AF:
0.243
AC:
1173
AN:
4822
European-Finnish (FIN)
AF:
0.137
AC:
1456
AN:
10614
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.209
AC:
14215
AN:
67928
Other (OTH)
AF:
0.157
AC:
332
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1003
2006
3008
4011
5014
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.178
Hom.:
985
Bravo
AF:
0.142
Asia WGS
AF:
0.138
AC:
483
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.71
DANN
Benign
0.57
PhyloP100
-0.91
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9278; hg19: chr7-150750980; API